Loading...
Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis
The disease of transthyretin (TTR) amyloidosis (ATTR) has been known since the 1960s, and during the past 60 or so years, there has been a sustained period of steady discoveries that have led to the current model of ATTR pathogenesis. More recent research has achieved major advances in both diagnost...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2024-09-01
|
| Serier: | Pharmaceuticals |
| Fag: | |
| Online adgang: | https://www.mdpi.com/1424-8247/17/9/1225 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|